verify cryptocurrency searches

According to the key industrial fields mentioned in the action plan, Shanghai's local semiconductor leading enterprises, pharmaceutical leading enterprises and new material leading enterprises are also expected to benefit from the merger and acquisition plan.Shanghai state-owned companies are expected to directly benefit from the action plan. According to the statistics of Securities Times and Data Treasure, there are 37 A-shares owned by Shanghai State-owned Assets with a market value of less than 10 billion yuan. Among them, the market value of Kaikai Industrial, Chuangchuang International, First Pharmaceutical and other stocks is less than 3 billion yuan, and the market value of Yatong, Changjiang Investment, Changlian, Shanghai Jiubai and *ST Tianwo is less than 4 billion yuan.Analysts said that the plan is expected to benefit Shanghai local stocks from multiple dimensions.

According to the key industrial fields mentioned in the action plan, Shanghai's local semiconductor leading enterprises, pharmaceutical leading enterprises and new material leading enterprises are also expected to benefit from the merger and acquisition plan.Analysts said that the plan is expected to benefit Shanghai local stocks from multiple dimensions.Judging from the market performance, the average growth rate of 41 key sector stocks since September 18 is close to 56%, far outperforming the performance of the broader market in the same period. Among them, two stocks of Xinxiangwei and SMIC doubled. Xinxiangwei's main business focuses on the research, development, design and sales of display chips, and is committed to providing complete display chip system solutions.

After-hours big profits are related to mergers and acquisitions, restructuring, Shanghai state-owned shares have these.According to data treasure statistics, excluding central enterprises and state-owned enterprises, among the above three sectors, there are 41 Shanghai local stocks with a market value exceeding 10 billion yuan.From the perspective of institutional attention, Zhongwei Company and Weir Co., Ltd. have more than 30 institutional ratings, while Hengxuan Technology, Lanqi Technology, UIH Medical and Microelectrophysiology -U have more than 20 institutional ratings.